晚期心力衰竭的静脉连续家庭内诺托普疗法:从观察性回顾性研究的见解
Piero Gentile1, Gabriella Masciocco1, Matteo Palazzini1
1De Gasperis Cardio Center and Transplant Center, Niguarda Hospital, Milan, Italy.
European journal of internal medicine
|July 1, 2023
概括
持续在家输注内类药物显著减少住院,并改善了先进心力衰竭 (HF) 患者器官功能和生活质量. 这种疗法为管理复杂的HF病例提供了可行的选择.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭管理的管理
背景情况:
- 静脉内托普支持是晚期心力衰竭 (HF) 的关键疗法.
- 它作为移植,机械支或息治疗的桥梁,缺乏关于风险和益处的强有力的证据.
研究的目的:
- 评估门诊内疗法对晚期HF患者的影响.
- 评估住院,生活质量,不良事件和器官损伤的演变.
主要方法:
- 从2014年至2021年治疗的27名晚期HF患者的回顾性单中心研究.
- 分析比较了在开始家庭内托普注射之前和之后的结果.
主要成果:
- 住院病例显著下降 (46与25相比,p<0.001).
- 观察到的 natriuretic ,和肝功能 (p<0.001) 的改善.
- 53%的患者报告生活质量有所改善,2例心律失常和7例与导管相关的住院治疗发生.
结论:
- 在家中注入内的输液可以减少入院在选定的高级HF患者.
- 这种疗法可以改善末端器官损伤和生活质量.
- 提供了关于启动和监测家庭内注射的实用指南.
相关概念视频
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure Drugs: Inotropic Agents
635
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
635
Continuous Renal Replacement Therapy
54
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
54
Heart Failure IV: Classification and Diagnostic Evaluation
20
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
20
Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16


